Franziska Blaeschke
- Oncology top 5%
- CAR-T cell therapy research 26
- Cancer Immunotherapy and Biomarkers 3
- Immunology top 5%
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 7
- Genetics top 10%
- Virus-based gene therapy research 7
-
- Viral Infectious Diseases and Gene Expression in Insects 6
- CRISPR and Genetic Engineering 4
-
- Cytomegalovirus and herpesvirus research 3
- Co-authors
- Tobias FeuchtingerTheresa KaeuferleAlexander MarsonSemjon WillierJudith FeuchtMichaela DöringDana StengerVinh Nguyen
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Franziska Blaeschke
31 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 832
- Immunology 449
- Genetics 288
- Molecular Biology 658
- Business and International Management 18
Countries citing papers authored by Franziska Blaeschke
This map shows the geographic impact of Franziska Blaeschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Blaeschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Blaeschke more than expected).
Fields of papers citing papers by Franziska Blaeschke
This network shows the impact of papers produced by Franziska Blaeschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Blaeschke. The network helps show where Franziska Blaeschke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franziska Blaeschke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 12 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 129 | |
| 8 | 2020 | 44 | |
| 9 | 2020 | 130 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 21 | |
| 12 | 2020 | 55 | |
| 13 | 2019 | 31 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 152 | |
| 16 | 2019 | 98 | |
| 17 | 2018 | 118 | |
| 18 | 2017 | 14 | |
| 19 | 2017 | 40 | |
| 20 | 2016 | 20 |
About Franziska Blaeschke
Franziska Blaeschke is a scholar working on Oncology, Immunology and Genetics, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (26 papers), Immune Cell Function and Interaction (10 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), CRISPR and Genetic Engineering (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Oncology (832 citations), Immunology (449 citations) and Genetics (288 citations). Franziska Blaeschke has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Tobias Feuchtinger, Theresa Kaeuferle, Alexander Marson, Semjon Willier, Judith Feucht, Michaela Döring, Dana Stenger, Vinh Nguyen, Chun Ye and Ramin Lotfi. Their work appears in journals such as Blood, Oncotarget, Molecular Therapy, Nature Genetics and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.